vs
Side-by-side financial comparison of GRACO INC (GGG) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
GRACO INC is the larger business by last-quarter revenue ($593.2M vs $493.8M, roughly 1.2× Pediatrix Medical Group, Inc.). GRACO INC runs the higher net margin — 22.3% vs 6.8%, a 15.5% gap on every dollar of revenue. On growth, GRACO INC posted the faster year-over-year revenue change (8.1% vs -1.7%). Over the past eight quarters, GRACO INC's revenue compounded faster (9.8% CAGR vs -0.1%).
Graco Inc. is an American industrial company that specializes in the development and manufacturing of fluid-handling systems and products. The company is headquartered in Minneapolis, Minnesota, and markets its products to customers worldwide.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
GGG vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $593.2M | $493.8M |
| Net Profit | $132.5M | $33.7M |
| Gross Margin | 51.7% | — |
| Operating Margin | 26.7% | 9.9% |
| Net Margin | 22.3% | 6.8% |
| Revenue YoY | 8.1% | -1.7% |
| Net Profit YoY | 21.9% | 10.5% |
| EPS (diluted) | $0.78 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $593.2M | $493.8M | ||
| Q3 25 | $543.4M | $492.9M | ||
| Q2 25 | $571.8M | $468.8M | ||
| Q1 25 | $528.3M | $458.4M | ||
| Q4 24 | $548.7M | $502.4M | ||
| Q3 24 | $519.2M | $511.2M | ||
| Q2 24 | $553.2M | $504.3M | ||
| Q1 24 | $492.2M | $495.1M |
| Q4 25 | $132.5M | $33.7M | ||
| Q3 25 | $137.6M | $71.7M | ||
| Q2 25 | $127.6M | $39.3M | ||
| Q1 25 | $124.1M | $20.7M | ||
| Q4 24 | $108.7M | $30.5M | ||
| Q3 24 | $122.2M | $19.4M | ||
| Q2 24 | $133.0M | $-153.0M | ||
| Q1 24 | $122.2M | $4.0M |
| Q4 25 | 51.7% | — | ||
| Q3 25 | 53.2% | — | ||
| Q2 25 | 52.4% | — | ||
| Q1 25 | 52.6% | — | ||
| Q4 24 | 50.9% | — | ||
| Q3 24 | 53.2% | — | ||
| Q2 24 | 54.4% | — | ||
| Q1 24 | 54.1% | — |
| Q4 25 | 26.7% | 9.9% | ||
| Q3 25 | 30.3% | 13.8% | ||
| Q2 25 | 27.5% | 12.8% | ||
| Q1 25 | 27.3% | 7.0% | ||
| Q4 24 | 23.7% | 7.8% | ||
| Q3 24 | 28.1% | 6.6% | ||
| Q2 24 | 29.2% | -31.3% | ||
| Q1 24 | 27.0% | 3.2% |
| Q4 25 | 22.3% | 6.8% | ||
| Q3 25 | 25.3% | 14.5% | ||
| Q2 25 | 22.3% | 8.4% | ||
| Q1 25 | 23.5% | 4.5% | ||
| Q4 24 | 19.8% | 6.1% | ||
| Q3 24 | 23.5% | 3.8% | ||
| Q2 24 | 24.0% | -30.3% | ||
| Q1 24 | 24.8% | 0.8% |
| Q4 25 | $0.78 | $0.40 | ||
| Q3 25 | $0.82 | $0.84 | ||
| Q2 25 | $0.76 | $0.46 | ||
| Q1 25 | $0.72 | $0.24 | ||
| Q4 24 | $0.63 | $0.37 | ||
| Q3 24 | $0.71 | $0.23 | ||
| Q2 24 | $0.77 | $-1.84 | ||
| Q1 24 | $0.71 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $624.1M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $2.7B | $865.9M |
| Total Assets | $3.3B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $624.1M | $375.2M | ||
| Q3 25 | $618.7M | $340.1M | ||
| Q2 25 | $534.9M | $224.7M | ||
| Q1 25 | $536.1M | $99.0M | ||
| Q4 24 | $675.3M | $229.9M | ||
| Q3 24 | $764.5M | $103.8M | ||
| Q2 24 | $666.0M | $19.4M | ||
| Q1 24 | $622.7M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $2.7B | $865.9M | ||
| Q3 25 | $2.6B | $890.7M | ||
| Q2 25 | $2.5B | $833.8M | ||
| Q1 25 | $2.5B | $789.2M | ||
| Q4 24 | $2.6B | $764.9M | ||
| Q3 24 | $2.5B | $732.5M | ||
| Q2 24 | $2.4B | $706.5M | ||
| Q1 24 | $2.3B | $856.2M |
| Q4 25 | $3.3B | $2.2B | ||
| Q3 25 | $3.2B | $2.2B | ||
| Q2 25 | $3.0B | $2.1B | ||
| Q1 25 | $3.0B | $2.0B | ||
| Q4 24 | $3.1B | $2.2B | ||
| Q3 24 | $3.0B | $2.1B | ||
| Q2 24 | $2.9B | $2.0B | ||
| Q1 24 | $2.8B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $196.3M | $114.1M |
| Free Cash FlowOCF − Capex | $184.3M | — |
| FCF MarginFCF / Revenue | 31.1% | — |
| Capex IntensityCapex / Revenue | 2.0% | — |
| Cash ConversionOCF / Net Profit | 1.48× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $637.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $196.3M | $114.1M | ||
| Q3 25 | $179.2M | $137.3M | ||
| Q2 25 | $182.7M | $137.2M | ||
| Q1 25 | $125.4M | $-117.5M | ||
| Q4 24 | $185.2M | $133.0M | ||
| Q3 24 | $178.6M | $91.8M | ||
| Q2 24 | $139.0M | $107.0M | ||
| Q1 24 | $118.9M | $-125.2M |
| Q4 25 | $184.3M | — | ||
| Q3 25 | $175.7M | — | ||
| Q2 25 | $163.1M | — | ||
| Q1 25 | $114.8M | — | ||
| Q4 24 | $171.3M | — | ||
| Q3 24 | $159.2M | — | ||
| Q2 24 | $102.7M | — | ||
| Q1 24 | $81.7M | — |
| Q4 25 | 31.1% | — | ||
| Q3 25 | 32.3% | — | ||
| Q2 25 | 28.5% | — | ||
| Q1 25 | 21.7% | — | ||
| Q4 24 | 31.2% | — | ||
| Q3 24 | 30.7% | — | ||
| Q2 24 | 18.6% | — | ||
| Q1 24 | 16.6% | — |
| Q4 25 | 2.0% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 3.7% | — | ||
| Q2 24 | 6.6% | — | ||
| Q1 24 | 7.6% | — |
| Q4 25 | 1.48× | 3.39× | ||
| Q3 25 | 1.30× | 1.91× | ||
| Q2 25 | 1.43× | 3.49× | ||
| Q1 25 | 1.01× | -5.66× | ||
| Q4 24 | 1.70× | 4.36× | ||
| Q3 24 | 1.46× | 4.72× | ||
| Q2 24 | 1.05× | — | ||
| Q1 24 | 0.97× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GGG
| Industrial | $284.3M | 48% |
| Contractor | $265.5M | 45% |
| Other | $43.4M | 7% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
